Cancer Population Science
Aimed at reducing the burden from cancer on a population level, the Cancer Population Science (CPS) Program is conducting observational and interventional studies that focus on primary prevention, early detection, health outcomes and the delivery of cancer care to diverse communities.
Cancer is a major burden on society in the United States and across the world. In 2018, an estimated 1.7 million new cases of cancer will be diagnosed in the United States over 600,000 people will die from the disease. According to the National Cancer Institute, the estimated national expenditures for cancer care in the United States in 2017 were $147.3 billion and costs are likely to increase. While cancer affects all population groups, the disease may have a larger or more severe impact on some groups over others, and understanding and addressing these health disparities remains crucial. Worldwide, cancer is among the leading causes of death with over half of all new cancer cases, and two thirds of cancer deaths occurring in less developed regions.
Major research themes
Members of the Cancer Population Science Program are zeroing in on key research themes across the cancer care continuum. We are doing this locally within our catchment area as well
- Primary Prevention
- Risk Assessment & Early Detection
- Health Outcomes, Survivorship and Care Delivery
- Global Health
The Cancer Population Science Program promotes impactful clinical practice as well as public policy, conducts diverse research across the cancer care continuum and translates observational programmatic findings to large multicenter clinical trials, cutting the burden of cancer across the globe.
Leadership
The Cancer Population Science Program at the Herbert Irving Comprehensive Cancer Center (HICCC) is led by:
